High Point Bank & Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$100K Sell
477
-240
-33% -$49.7K 0.03% 172
2016
Q3
$165K Buy
717
+25
+4% +$6.11K 0.04% 139
2016
Q2
$160K Buy
692
+115
+20% +$26.5K 0.04% 144
2016
Q1
$155K Sell
577
-150
-21% -$42.9K 0.04% 146
2015
Q4
$227K Buy
727
+250
+52% +$74.4K 0.06% 121
2015
Q3
$144K Hold
477
0.04% 157
2015
Q2
$144K Sell
477
-2
-0.4% -$597 0.04% 163
2015
Q1
$142K Buy
+479
New +$137K 0.04% 169

Other funds holding AGN

High Point Bank & Trust's AGN Position: Q4 2016 in Review

High Point Bank & Trust reduced its Allergan plc (AGN) stake by 33% in Q4 2016, selling an estimated $49.7K and leaving 477 shares worth $100K. The position accounts for 0.03% of the portfolio, ranked #172.

High Point Bank & Trust first reported a position in AGN in Q1 2015 and has held it in 8 quarters since. The position peaked at $227K in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • High Point Bank & Trust held 477 shares of Allergan plc worth $100K as of Q4 2016.
  • High Point Bank & Trust sold 240 Allergan plc shares in Q4 2016, an estimated $49.7K.
  • Allergan plc made up 0.03% of High Point Bank & Trust's portfolio in Q4 2016, its #172 holding.
  • High Point Bank & Trust first reported a position in Allergan plc in Q1 2015 and has held it in 8 quarters since.
  • High Point Bank & Trust's Allergan plc position peaked at $227K in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.